Lotus Eye Hospital and Institute (LOTUSEYE) — Board Meeting

📢 Key Event
Board approved unaudited Q1 results and limited review report

🔄 What Changed
Net profit improved to ₹61.37 lakhs from a loss of ₹31.95 lakhs; total income increased to ₹1,726.79 lakhs

💡 Investor Takeaway
Profit turned positive this quarter, indicating early signs of recovery.

The board approved the standalone unaudited financial results for Q1 June 2026 and the limited review report, confirming net profit of ₹61.37 lakhs versus a loss of ₹31.95 lakhs in the prior quarter, with total income rising to ₹1,726.79 lakhs and expenses at ₹1,625.44 lakhs; the meeting ran from 4:50 PM to 5:30 PM on August 10, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LOTUSEYE ✨ Ask AI About This

About Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹226.68 Cr P/E: 1362.5 ROE: 0.3% ROCE: 2.5%

View full LOTUSEYE stock details →

📡 Get AI alerts when LOTUSEYE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LOTUSEYE — Free

💡 Ask AI about this filing

"What is the year-on-year revenue growth?" "How does this profit compare to industry peers?" "What are the expected margins for the next quarter?"

Ask AI Free →

📊 More LOTUSEYE filings

See all LOTUSEYE filings →

🔥 Also filed on 10 August 2026

TIMKEN Timken India Limited Financial Results DOMS DOMS Industries Limited Corporate Action HGS Hinduja Global Solutions Limited Financial Results SUNDRMFAST Sundram Fasteners Limited Financial Results AMJLAND Amj Land Holdings Limited Annual Report KANSAINER Kansai Nerolac Paints Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LOTUSEYE files new disclosures

Track LOTUSEYE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LOTUSEYE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd